UNIPHAR PLC

UPR
Real-time Quote. Real-time  - 01/19 11:30:13 am
4.2EUR +4.48%
Business Summary
Consumer Non-Cyclicals
Food & Drug Retailing
 Food & Drug Retailing
  Drug Retailers
   Other Drug Retailers
Uniphar PLC is an Ireland-based company. The Company is a diversified healthcare services company. It serves multinational pharmaceutical and medical technology manufacturers across three divisions: Commercial & Clinical, Product Access and Supply Chain & Retail. Through commercial & clinical division, the Company provides sales, marketing and distribution solutions to multinational pharmaceutical and medical device manufacturers on an outsourced basis. Product Access division offers two service offerings: On Demand Access and Exclusive Access. On Demand Access is a pharmacy led solutions for sourcing and supplying unlicensed medicines to meet the needs of both retail and hospital pharmacists. Exclusive Access is a manufacturer led solution for controlling the release of specialty medicines for specifically approved patient populations. Supply Chain & Retail provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare and animal health products.

Number of employees : 1 200 people.
Sales per Business
20192020
Supply Chain and Retail1 329.0179.8%1 366.5774.9%
Commercial and Clinical204.0312.3%269.7814.8%
Product Access132.257.9%187.5110.3%
EUR in Million
Sales per region
20192020
Ireland1 476.2588.6%1 540.3884.5%
United Kingdom152.629.2%214.3511.8%
Rest of the World36.412.2%69.123.8%
EUR in Million
Managers
Name Title
Ger Rabbette Chief Executive Officer & Director
Tim Dolphin Chief Financial Officer & Director
Maurice Pratt Non-Executive Chairman
Paul Hogan Independent Non-Executive Director
Jeffrey Berkowitz Independent Non-Executive Director
Sue Webb Independent Non-Executive Director
James Gaul Independent Non-Executive Director
Elizabeth Hoctor Independent Non-Executive Director
Brian O'Shaughnessy Director-IR & Corporate Development
Aisling McCarthy Secretary & General Counsel
Shareholders
Name Equities %
Polar Capital LLP 19,116,145 7.00%
Mackenzie Financial Corp. 17,374,939 6.36%
Sisk Family 16,152,373 5.92%
Allianz Global Investors GmbH 13,700,000 5.02%
Mackenzie Investments Europe Ltd. 11,332,114 4.15%
Ger Rabbette 8,203,310 3.00%
Danske Bank A/S (Investment Management) 8,149,190 2.98%
AIB Group (Private Equity) 8,091,304 2.96%
Mackenzie Investments Asia Ltd. 7,985,386 2.92%
Tim Dolphin 5,586,322 2.05%
Company contact information
Citywest Business Park 4045 Kingswood Road
IE-D24 VO6K Dublin


Phone : +353 1 428 7777
Fax : +353 1428 7776
web site : https://www.uniphar.ie/
Markets and indexes
- Euronext Growth Dublin
- Euronext Growth All-Share / ISEQ 20, ISEQ 20 Capped, PEA
Stock Exchange Codes
- Reuters Code :  UPR.D
Sector Other Drug Retailers
1st jan.Capi. (M$)
UNIPHAR PLC-19.60%1 244
WALGREENS BOOTS ALLIANCE, INC.4.10%46 202
MCKESSON CORPORATION1.60%38 558
JD HEALTH INTERNATIONAL INC.7.24%27 019
CARDINAL HEALTH, INC.2.14%14 819
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD1.51%7 943
SINOPHARM GROUP CO., LTD.8.49%7 369
YIFENG PHARMACY CHAIN CO., LTD.-0.22%6 221
WELCIA HOLDINGS CO., LTD.-11.00%5 812
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.-1.45%5 167
EBOS GROUP LIMITED-1.94%5 019
CLICKS GROUP LIMITED-2.50%4 844
MATSUKIYOCOCOKARA & CO.-8.33%4 620
JOINTOWN PHARMACEUTICAL GROUP CO., LTD-3.06%4 108
PING AN HEALTHCARE AND TECHNOLOGY COMPANY LIMITED-3.70%3 957
MEDIPAL HOLDINGS CORPORATION-4.36%3 777
GALENICA AG-7.00%3 442
YIXINTANG PHARMACEUTICAL GROUP CO., LTD.-5.61%3 411
SUZUKEN CO., LTD.-0.15%2 544
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.-3.46%2 237
SHOP APOTHEKE EUROPE N.V.-5.38%2 198
Brand Portfolio
» More brands of Uniphar Plc